Coverage varies across the entire class of GLP-1 receptor agonists, with diabetes indications typically covered but obesity indications excluded in most states
Modest Weight-Neutral or Loss Effect: While not a primary weight loss drug, metformin is generally considered weight-neutral and in some cases, can lead to a modest amount of weight loss, which can be an added benefit for many individuals
All images were captured using an A1 + R laser confocal microscope (Nikon Corporation)
In this view, the seminal contribution of Clifton Bogardus and his group is valuable: in a now historic longitudinal study conducted on the Pima Indians, they demonstrated that the progression from a condition of normoglycemia to overt T2D is totally attributable to the reduction in insulin secretion [30]
Its part of a class of medications called GLP-1 and GIP receptor agonists, meaning it mimics the natural gut hormones your body releases after eating